Reengineering the Specificity of the Highly Selective Clostridium botulinum Protease via Directed Evolution
Authors:
- Rebekah P. DyerRDRebekah P. Dyer
- Hariny M. IsodaHIHariny M. Isoda
- Gabriela S. SalcedoGSGabriela S. Salcedo
- Gaetano SpecialeGSGaetano Speciale
- Madison H. FletcherMFMadison H. Fletcher
- Linh Q. LeLLLinh Q. Le
- Yi LiuYLYi Liu
- Shiazah Z. MalikSMShiazah Z. Malik
- Edwin J. Vazquez-CintronEdwin J. Vazquez-Cintron
- Andrew C. ChuACAndrew C. Chu
- David C. RuppDRDavid C. Rupp
- Birgitte P.S. JackyBJBirgitte P.S. Jacky
Preprint
Abstract
The botulinum neurotoxin serotype A (BoNT/A) cuts a single peptide bond in SNAP25, an activity used to treat a wide range of diseases. Reengineering the substrate specificity of BoNT/A’s protease domain (LC/A) could expand its therapeutic applications; however, LC/A’s extended substrate recognition (≈60 residues) challenges conventional approaches. We report a directed evolution method for retargeting LC/A’s substrate and retaining its exquisite specificity. The resultant eight-mutation LC/A (omLC/A) has improved cleavage specificity and catalytic efficiency (1300- and 120-fold, respectively) for SNAP23 versus SNAP25 compared to a previously reported LC/A variant. Importantly, the BoNT/A holotoxin equipped with omLC/A infiltrates neurons and retains its SNAP23 activity. The identification of substrate control loops outside BoNT/A’s active site could guide the design of improved BoNT proteases and inhibitors. One Sentence Summary: Directed evolution of the BoNT/A protease targets a new cellular protein, SNAP23, expanding its therapeutic potential.Keywords
All Related Versions
- Published version: Scientific Reports, 12 (1), 1.
This publication has 40 references indexed in Scilit:
- Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cellsJournal of Neurochemistry, 2013
- When Second Best Is Good Enough: Another Probabilistic Look at Saturation MutagenesisApplied and Environmental Microbiology, 2012
- Proteases as therapeuticsBiochemical Journal, 2011
- VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasionJournal of Cell Science, 2009
- Highly active and selective endopeptidases with programmed substrate specificitiesNature Chemical Biology, 2008
- Mechanism of Substrate Recognition by Botulinum Neurotoxin Serotype AJournal of Biological Chemistry, 2007
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Inhibition of Release of Neurotransmitters from Rat Dorsal Root Ganglia by a Novel Conjugate of a Clostridium botulinumToxin A Endopeptidase Fragment and Erythrina cristagalliLectinJournal of Biological Chemistry, 2002
- Arg362 and Tyr365 of the Botulinum Neurotoxin Type A Light Chain Are Involved in Transition State StabilizationBiochemistry, 2002